These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31096725)
21. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Minniti G; Lanzetta G; Scaringi C; Caporello P; Salvati M; Arcella A; De Sanctis V; Giangaspero F; Enrici RM Int J Radiat Oncol Biol Phys; 2012 May; 83(1):93-9. PubMed ID: 22079725 [TBL] [Abstract][Full Text] [Related]
22. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. Inogés S; Tejada S; de Cerio AL; Gállego Pérez-Larraya J; Espinós J; Idoate MA; Domínguez PD; de Eulate RG; Aristu J; Bendandi M; Pastor F; Alonso M; Andreu E; Cardoso FP; Valle RD J Transl Med; 2017 May; 15(1):104. PubMed ID: 28499389 [TBL] [Abstract][Full Text] [Related]
23. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial. Rapp M; Grauer OM; Kamp M; Sevens N; Zotz N; Sabel M; Sorg RV Trials; 2018 May; 19(1):293. PubMed ID: 29801515 [TBL] [Abstract][Full Text] [Related]
24. Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases. Lombardi G; Caccese M; Bellu L; Pambuku A; Bergo E; Berti F; Gardiman MP; Della Puppa A; Denaro L; Dal Pos S; Zagonel V Anticancer Drugs; 2018 Oct; 29(9):924-928. PubMed ID: 30080691 [TBL] [Abstract][Full Text] [Related]
25. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report. Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499 [TBL] [Abstract][Full Text] [Related]
26. A single-dose, randomized, cross-over, two-way, open-label study for comparing the absorption of boswellic acids and its lecithin formulation. Riva A; Morazzoni P; Artaria C; Allegrini P; Meins J; Savio D; Appendino G; Schubert-Zsilavecz M; Abdel-Tawab M Phytomedicine; 2016 Nov; 23(12):1375-1382. PubMed ID: 27765357 [TBL] [Abstract][Full Text] [Related]
27. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R; Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067 [TBL] [Abstract][Full Text] [Related]
28. Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. Laprie A; Ken S; Filleron T; Lubrano V; Vieillevigne L; Tensaouti F; Catalaa I; Boetto S; Khalifa J; Attal J; Peyraga G; Gomez-Roca C; Uro-Coste E; Noel G; Truc G; Sunyach MP; Magné N; Charissoux M; Supiot S; Bernier V; Mounier M; Poublanc M; Fabre A; Delord JP; Cohen-Jonathan Moyal E BMC Cancer; 2019 Feb; 19(1):167. PubMed ID: 30791889 [TBL] [Abstract][Full Text] [Related]
29. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age. Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238 [TBL] [Abstract][Full Text] [Related]
30. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients. Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide. Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530 [TBL] [Abstract][Full Text] [Related]
32. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide. Peponi E; Tourkantonis I; Tasiou I; Pavlidis N; Pentheroudakis G; Tsekeris P J BUON; 2014; 19(3):718-23. PubMed ID: 25261658 [TBL] [Abstract][Full Text] [Related]
34. Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients. Carpentier AF; Ferrari D; Bailon O; Ursu R; Banissi C; Dubessy AL; Belin C; Levy C Eur J Neurol; 2012 Oct; 19(10):1337-42. PubMed ID: 22650322 [TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635 [TBL] [Abstract][Full Text] [Related]
37. A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. Shenouda G; Souhami L; Petrecca K; Owen S; Panet-Raymond V; Guiot MC; Corredor AG; Abdulkarim B Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):487-494. PubMed ID: 28011051 [TBL] [Abstract][Full Text] [Related]
38. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme. Abrey LE Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881 [No Abstract] [Full Text] [Related]
39. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646 [TBL] [Abstract][Full Text] [Related]
40. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme. Reddy K; Gaspar LE; Kavanagh BD; Chen C J Med Imaging Radiat Oncol; 2014 Dec; 58(6):714-21. PubMed ID: 24975917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]